Agency Information Collection Activities; Submission for OMB Review; Comment Request
FDA has submitted a proposed information collection to OMB for review, which may affect cosmetics facility registration, product listing, and other MoCRA-related reporting requirements. This is a procedural step that could lead to new or modified compliance obligations.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Indie beauty brands, contract manufacturers, private-label makers, importers/distributors should confirm how it applies to their specific situation before acting. There is a time constraint attached: No immediate deadline; OMB review typically takes 30-60 days. Comment period may follow.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA submitted a proposed information collection to OMB for review and clearance, potentially leading to changes in reporting requirements for cosmetics facilities and products under MoCRA.
Who it affects
Indie beauty brands, contract manufacturers, private-label makers, importers/distributors
What you must do
Monitor the OMB review process and be prepared to adjust registration and listing procedures once the final collection is approved.
Deadline
No immediate deadline; OMB review typically takes 30-60 days. Comment period may follow.
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor
- New Jersey bans some products with toxic PFAS chemicals. Here’s what to know - WHYY
- Implementing MoCRA: FDA Releases New Draft Guidances on Insanitary Conditions for Tattoo Ink and Cosmetic Product Registration & Listing - Food and Drug Law Institute (FDLI)
- France bans PFAS in cosmetics – COSlaw.eu - Guiding through EU Cosmetics Regulations - COSlaw.eu
- Illinois Governor Signs Bill Banning Intentionally Added PFAS in Certain Consumer Products and Requiring IEPA to Prepare Report on Fluoropolymers by August 1, 2027 - Bergeson & Campbell